N Engl J Med 364(6):514523 Pavel ME et al (2017) Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Adverse effects associated with BPC-157 are minimal, with only mild and temporary discomfort reported at the injection site or minor gastrointestinal disturbances in some cases
And we bring it right to your doorstep, whether you're in downtown Philadelphia or the suburbs of Pittsburgh
Dietary modulation of endothelial function: implications for cardiovascular disease
This inflammation spreads to the brain, as peripheral cytokines cross the BBB, disrupting neuronal function and facilitating neuroinflammation (Rodrigues et al., 2023)